Zura Bio Limited Class A Ordinary Shares (ZURA) is a publicly traded Healthcare sector company. As of May 21, 2026, ZURA trades at $4.10 with a market cap of $390.91M and a P/E ratio of -3.86. ZURA moved +2.38% today. Year to date, ZURA is -14.90%; over the trailing twelve months it is +281.78%. Its 52-week range spans $0.97 to $7.44. Analyst consensus is strong buy with an average price target of $16.40. Rallies surfaces ZURA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ZURA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $4.10 |
| Market Cap | $390.91M |
| P/E Ratio | -3.86 |
| EPS | $-1.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.44 |
| 52-Week Low | $0.97 |
| Volume | 2.42K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-68.65M |
| Gross Margin | 0.00% |
5 analysts cover ZURA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.40.